Efficacy and Safety of BIIB111 for the Treatment of Choroideremia

The requested reference [3c1707d671559dfddf9ed71be64c13312435c3fc] no longer exists in our database. It has been replaced by the current reference: [fde269c4f9d23309a7c8661b20db7ff5e6fcaa80]

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The objective of the study is to evaluate the efficacy and safety of a single sub-retinal injection of BIIB111 in participants with choroideremia (CHM).
Epistemonikos ID: 90462f7e0d1d0d0a7fbbe43cb30fd914cc652152
First added on: May 21, 2024